OVERWEIGHT AND/OR OBESITY
Clinical trials for OVERWEIGHT AND/OR OBESITY explained in plain language.
Never miss a new study
Get alerted when new OVERWEIGHT AND/OR OBESITY trials appear
Sign up with your email to follow new studies for OVERWEIGHT AND/OR OBESITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New weekly shot could help diabetics shed pounds
Disease control OngoingThis Phase 3 trial tests a new medicine called MET097, given as a weekly injection, to help adults with overweight or obesity and type 2 diabetes lose weight. About 999 people will take part, with two-thirds getting the real drug and one-third getting a placebo. The study lasts a…
Matched conditions: OVERWEIGHT AND/OR OBESITY
Phase: PHASE3 • Sponsor: Pfizer • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Can a chatbot help young adults lose weight? new study investigates
Disease control OngoingThis study tests whether adding an AI chatbot to a 12-week smartphone weight loss program helps young adults with overweight or obesity lose more weight and stay engaged. Twenty participants will either get the standard program or the program plus a chatbot for extra support. Res…
Matched conditions: OVERWEIGHT AND/OR OBESITY
Phase: NA • Sponsor: University of North Carolina, Chapel Hill • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Smartphone app and glucose sensor aim to boost weight loss
Symptom relief OngoingThis study tests a smartphone app called eTRIP, which uses artificial intelligence to help people with overweight or obesity make healthier food choices and stick to their weight loss goals. Some participants also wear a continuous glucose monitor for 10 days to see how their blo…
Matched conditions: OVERWEIGHT AND/OR OBESITY
Phase: NA • Sponsor: National University Health System, Singapore • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
Pfizer tests experimental drug to slow stomach emptying in obesity
Knowledge-focused OngoingThis early-stage study tests an experimental drug called PF-08653944 in 20 overweight or obese adults. Researchers want to see how it affects the speed at which the stomach empties food, using a common painkiller as a marker. The main goals are to understand the drug's effects an…
Matched conditions: OVERWEIGHT AND/OR OBESITY
Phase: PHASE1 • Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Jul 11, 2026 00:00 UTC